<SEC-DOCUMENT>0001144204-16-134769-index.html : 20161115
<SEC-HEADER>0001144204-16-134769.hdr.sgml : 20161115
<ACCEPTANCE-DATETIME>20161115171147
ACCESSION NUMBER:		0001144204-16-134769
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		12
CONFORMED PERIOD OF REPORT:	20161115
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20161115
DATE AS OF CHANGE:		20161115

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Synthetic Biologics, Inc.
		CENTRAL INDEX KEY:			0000894158
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				133808303
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-12584
		FILM NUMBER:		162000511

	BUSINESS ADDRESS:	
		STREET 1:		617 DETROIT STREET, SUITE 100
		CITY:			ANN ARBOR
		STATE:			MI
		ZIP:			48104
		BUSINESS PHONE:		(734) 332-7800

	MAIL ADDRESS:	
		STREET 1:		155 GIBBS STREET
		STREET 2:		SUITE 412
		CITY:			ROCKVILLE
		STATE:			MD
		ZIP:			20850

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ADEONA PHARMACEUTICALS, INC.
		DATE OF NAME CHANGE:	20081027

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PIPEX PHARMACEUTICALS, INC.
		DATE OF NAME CHANGE:	20061214

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SHEFFIELD PHARMACEUTICALS INC
		DATE OF NAME CHANGE:	19970730
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>v453193_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
Document 1 - file: v453193_8k.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1.1
<SEQUENCE>2
<FILENAME>v453193_ex1-1.htm
<DESCRIPTION>EXHIBIT 1.1
<TEXT>
Document 2 - file: v453193_ex1-1.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.1
<SEQUENCE>3
<FILENAME>v453193_ex4-1.htm
<DESCRIPTION>EXHIBIT 4.1
<TEXT>
Document 3 - file: v453193_ex4-1.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.2
<SEQUENCE>4
<FILENAME>v453193_ex4-2.htm
<DESCRIPTION>EXHIBIT 4.2
<TEXT>
Document 4 - file: v453193_ex4-2.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.3
<SEQUENCE>5
<FILENAME>v453193_ex4-3.htm
<DESCRIPTION>EXHIBIT 4.3
<TEXT>
Document 5 - file: v453193_ex4-3.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1A
<SEQUENCE>6
<FILENAME>v453193_ex5-1a.htm
<DESCRIPTION>EXHIBIT 5.1A
<TEXT>
Document 6 - file: v453193_ex5-1a.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1B
<SEQUENCE>7
<FILENAME>v453193_ex5-1b.htm
<DESCRIPTION>EXHIBIT 5.1B
<TEXT>
Document 7 - file: v453193_ex5-1b.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>8
<FILENAME>v453193_ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
Document 8 - file: v453193_ex99-1.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>9
<FILENAME>v453193_ex99-2.htm
<DESCRIPTION>EXHIBIT 99.2
<TEXT>
Document 9 - file: v453193_ex99-2.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>logo_ex5-1b.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 10 - file: logo_ex5-1b.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>logo_ex99-1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 11 - file: logo_ex99-1.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>logo_ex99-2.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 12 - file: logo_ex99-2.jpg

</DOCUMENT>
</SEC-DOCUMENT>